These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21273614)

  • 1. Successful S-1 monotherapy for chemorefractory thymic carcinoma.
    Koizumi T; Agatsuma T; Komatsu Y; Kubo K
    Anticancer Res; 2011 Jan; 31(1):299-301. PubMed ID: 21273614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-1 treatment for chemorefractory thymic carcinoma.
    Ono A; Naito T; Yamamoto N
    J Thorac Oncol; 2008 Sep; 3(9):1076. PubMed ID: 18758317
    [No Abstract]   [Full Text] [Related]  

  • 3. S-1 is an active anticancer agent for advanced thymic carcinoma.
    Okuma Y; Shimokawa T; Takagi Y; Hosomi Y; Iguchi M; Okamura T; Shibuya M
    Lung Cancer; 2010 Dec; 70(3):357-63. PubMed ID: 20951466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
    Kobayashi S; Fujino N; Suzuki S; Yanai M
    Respirology; 2009 Jul; 14(5):771-2. PubMed ID: 19659655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of oral squamous cell carcinoma responding to S-1].
    Harada K; Tamatani T; Bando T; Yoshida H
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1455-8. PubMed ID: 17876145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
    Harada K; Ferdous T; Yoshida H
    Oncol Rep; 2007 Nov; 18(5):1077-83. PubMed ID: 17914556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer.
    Kaira K; Naruse I; Imai H; Sunaga N; Hisada T; Motegi M; Asao T; Yamada M
    Chemotherapy; 2014; 60(5-6):356-9. PubMed ID: 26389778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of maxillary sinus carcinoma showing long time survival after lung metastasis with administration of S-1 as tumor dormancy therapy].
    Satoh A; Satoh T; Kaneta H; Kato T; Notani K; Kitagawa Y
    Gan To Kagaku Ryoho; 2007 May; 34(5):749-51. PubMed ID: 17496450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of thymidylate synthase (TS) activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity.
    Koga M; Anegawa E; Yoh J; Tsuyama H; Sakaino H; Iwamoto O; Koga C; Kusukawa J
    Br J Oral Maxillofac Surg; 2010 Mar; 48(2):88-93. PubMed ID: 19576666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].
    Osaki T; Takimoto T; Furukawa M; Inoue M; Okumura M; Niju T; Kijima T; Kumagai T; Yoshida M; Tachibana I; Kawase I
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1119-23. PubMed ID: 16912531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast].
    Kobayashi Y; Kadoya T; Kanno E; Sasada T; Kajitani K; Emi A; Shigematsu H; Masumoto N; Haruta R; Kataoka T; Arihiro K; Okada M
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1403-6. PubMed ID: 22996778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
    Ikeda H; Takebe Y; Irie A; Mizoguchi Y; Yamada K; Shibahara K; Inokuchi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):677-9. PubMed ID: 12795100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [S-1 monotherapy in patients with pretreated advanced non-small cell lung cancer].
    Hashizume T; Nakada Y
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):963-7. PubMed ID: 19542716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of multi-drug resistant breast cancer with liver metastasis treated effectively by S-1 monotherapy].
    Yoshida H; Yamamoto D; Kanematsu S; Tanaka K; Ah K
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2901-3. PubMed ID: 21160266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
    Kajikawa H; Nario K; Miyahara H
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):631-4. PubMed ID: 15114715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of cancer successfully treated by chemotherapy of S-1 as first-line chemotherapy].
    Kadono K; Kawamoto K; Park T
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2661-3. PubMed ID: 20009476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma--three cases.
    Komatsu Y; Koizumi T; Tanabe T; Hatayama O; Yasuo M; Okada M; Yamamoto H; Kubo K; Sasabayashi M; Tsunoda T
    Anticancer Res; 2006; 26(6C):4851-5. PubMed ID: 17214351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
    Harada K; Kawashima Y; Uchida D; Yoshida H
    Gan To Kagaku Ryoho; 2007 May; 34(5):745-7. PubMed ID: 17496449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
    Nakata E; Fukushima M; Takai Y; Nemoto K; Ogawa Y; Nomiya T; Nakamura Y; Milas L; Yamada S
    Oncol Rep; 2006 Sep; 16(3):465-71. PubMed ID: 16865244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.